ACTIVE

DNAVision

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-73,8 k €-195,2 %over 1 year

Gross margin-3,7 k €-108,3 %over 1 year

Equity-879,8 k €-9,1 %over 1 year

Workforce2,0 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

DNAVision is a Public limited company incorporated in 2004. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Charleroi. It employs on average 2,0 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0865.300.475
Incorporation: 13/05/2004
Legal form: Public limited company
Registered office: Avenue Georges Lemaitre 25
6041 Charleroi · WallonieSee on map
Contributed capital: 61 500,00 €
Latest accounts: 31/12/2025
Average workforce: 2,0 ETP

Activities (NACE)

72101Research and experimental development on natural sciences and engineering· main 72109Research and experimental development on natural sciences and engineering 72110Research and experimental development on biotechnology 72190Other research and experimental development on natural sciences and engineering 73100Advertising

Joint committees (2)

Signals

Healthy social debts

Financials

Source · NBB, 20 filings

Trend over 17 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	-3,7 k €	-108%	45 k €	+17.6%	38,3 k €	-1.1%	38,7 k €	-63.5%	106 k €
EBITDA	-72,1 k €	-233%	-21,6 k €	+22.2%	-27,8 k €	+71.8%	-98,6 k €	+39.6%	-163,3 k €
Operating result	-72,1 k €	-213%	-23,1 k €	+25.6%	-31 k €	+70.6%	-105,3 k €	+19.4%	-130,6 k €
Net result	-73,8 k €	-195%	-25 k €	+4.2%	-26,1 k €	+74.9%	-103,7 k €	+27.6%	-143,3 k €
Balance sheet
Equity	-879,8 k €	-9.1%	-806,1 k €	-3.2%	-781,1 k €	-3.5%	-755 k €	-15.9%	-651,3 k €
Total assets	27,8 k €	-47.3%	52,8 k €	-43.0%	92,6 k €	+41.6%	65,4 k €	-72.9%	241,6 k €
Cash	19,5 k €	-59.0%	47,4 k €	-42.8%	82,8 k €	+600%	11,8 k €	-22.3%	15,2 k €
Debts	907,7 k €	+5.7%	858,9 k €	-1.7%	873,7 k €	+6.5%	820,4 k €	-8.1%	893 k €
Other
Workforce	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP	-56.5%	4,6 ETP	0.0%	4,6 ETP

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 17 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Guy HELIN	Director16/12/2009 → 01/06/2028
Laurent ALEXANDRE	Managing director17/02/2012 → 01/06/2028Chairman of the board of directors16/12/2009 → 2009 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
REWISE0428.161.463Represented by Pierre ALCOVER	Auditor07/06/2012 → 2017 accounts
Sébastien MASSART	Director23/03/2012 → 2014 accounts

Other companies at this address

Avenue Georges Lemaitre 25 6041 Charleroi

Company	CBE no.
BIO.BE● Active	0861.738.595
Institut de Pathologie et de Génétique● Active	0408.333.871

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	21/09/2026	19/09/2025	29/08/2024	31/08/2023	13/10/2022	21/12/2021
General meeting	25/08/2026	26/08/2025	19/08/2024	31/07/2023	10/10/2022	06/12/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	25/08/2026	21/09/2026	French	PDF
Abridged model	31/12/2024	26/08/2025	19/09/2025	French	PDF
Abridged model	31/12/2023	19/08/2024	29/08/2024	French	PDF
Abridged model	31/12/2022	31/07/2023	31/08/2023	French	PDF
Abridged model	31/12/2021	10/10/2022	13/10/2022	French	PDF
Abridged model	31/12/2020	06/12/2021	21/12/2021	French	PDF
Abridged model	31/12/2019	25/11/2020	30/11/2020	French	PDF
Abridged model	31/12/2018	28/06/2019	21/08/2019	French	PDF
Abridged model	31/12/2017	27/12/2018	24/01/2019	French	PDF
Abridged model	31/12/2016	20/12/2017	09/03/2018	French	PDF
Abridged model	31/12/2015	26/08/2016	30/08/2016	French	PDF
Abridged model	31/12/2014	04/06/2015	29/07/2015	French	PDF
Abridged model	31/12/2013	05/06/2014	11/09/2014	French	PDF
Abridged model	31/12/2012	06/06/2013	23/07/2013	French	PDF
Abridged model	31/12/2011	07/06/2012	02/08/2012	French	PDF
Abridged model	31/12/2010	20/06/2011	13/07/2011	French	PDF
Abridged model	31/12/2009	16/06/2010	24/06/2010	French	PDF
Abridged model	31/12/2008	19/06/2009	01/07/2009	French	PDF
Abridged model	31/12/2007	12/06/2008	11/07/2008	French	PDF
Abridged model	31/12/2006	25/06/2007	29/06/2007	French	PDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 17 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Guy HELIN	Director16/12/2009 → 01/06/2028
Laurent ALEXANDRE	Managing director17/02/2012 → 01/06/2028Chairman of the board of directors16/12/2009 → 2009 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
REWISE0428.161.463Represented by Pierre ALCOVER	Auditor07/06/2012 → 2017 accounts
Sébastien MASSART	Director23/03/2012 → 2014 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates13/01/2022
DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Capital / shares22/01/2019
CAPITAL, ACTIONS
PDF
Mandates20/09/2016
DEMISSIONS, NOMINATIONS
PDF
Capital / shares13/09/2016
RAPPORTS — REDUCTION - AUGMENTATION DE CAPITAL - POUVOIRS,
PDF
Capital / shares19/06/2015
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates29/01/2014
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF
Capital / shares31/01/2013
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates18/07/2012
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings17 filings

Mandates

Guy HELIN

Laurent ALEXANDRE

REWISE

Sébastien MASSART

Université Libre de Bruxelles

IMPACTHEO

BIO.BE

Patrick DI STEFANO

Dim3

BNH BIOTECH SPRL

SPARAXIS

Jean-Claude HAVAUX

Show the 7 other mandates

2004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028

DNA Vision

Avenue Georges Lemaitre 25, 6041 Gosselies

Director

Managing director

AuditorRegistered auditor

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Avenue Georges Lemaitre 25, 6041 GosseliesCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00517510

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
DNAVisionCurrent		CBE
DNA Vision	accounts 2021 → 2025	Accounts 2025 · 2026-00517510

Events

2025
Annual accounts 2025-73,8 k €↓
2024
Annual accounts 2024-25 k €↑
2023
Annual accounts 2023-26,1 k €↑
2022
Annual accounts 2022-103,7 k €↑
2021
Annual accounts 2021-143,3 k €↑
2020
Annual accounts 2020-234,7 k €↓
2019
Annual accounts 2019-39,2 k €↓
2018
Annual accounts 20181,6 k €↑
2017
Annual accounts 2017-293,7 k €↑
2016
Annual accounts 2016-633,5 k €↓
2015
Annual accounts 2015-272,1 k €↑
2014
Annual accounts 2014-1,3 M €↓
2013
Annual accounts 2013-503,4 k €↓
2009
Annual accounts 2009-376 k €↓
2008
Annual accounts 2008180,1 k €↑
2007
Annual accounts 2007-44,3 k €↑
2006
Annual accounts 2006-230,7 k €
13/05/2004
IncorporationPublic limited company

DNAVision

Overview

Identity

Financials

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events